Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: An EAACI statement

The outbreak of the SARS‐CoV‐2‐induced coronavirus disease 2019 (COVID‐19) pandemic re‐shaped doctor‐patient interaction and challenged capacities of healthcare systems. It created many issues around the optimal and safest way to treat complex patients with severe allergic disease. A significant num...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Allergy
Main Authors: Vultaggio, Alessandra, Agache, Ioana, Akdis, Cezmi A., Akdis, Mubeccel, Bavbek, Sevim, Bossios, Apostolos, Bousquet, Jean, Boyman, Onur, Chaker, Adam M., Chan, Susan, Chatzipetrou, Alexia, Feleszko, Wojciech, Firinu, Davide, Jutel, Marek, Kauppi, Paula, Klimek, Ludger, Kolios, Antonios, Kothari, Akash, Kowalski, Marek L., Matucci, Andrea, Palomares, Oscar, Pfaar, Oliver, Rogala, Barbara, Untersmayr, Eva, Eiwegger, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Eaaci Position Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300800/
https://ncbi.nlm.nih.gov/pubmed/32500526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.14407
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados